Pierpaolo Risiglione

Dr. Pierpaolo Risiglione


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PRPierpaolo Risiglione
Pierpaolo Risiglione
LLLoredana Leggio
Loredana Leggio
SCSalvatore Antonio Maria Cubisino
Salvatore Antonio Maria Cubisino
Simona ReinaSimona Reina
Simona Reina
GPGreta Paternò
Greta Paternò
Angela MessinaAngela Messina
Angela Messina
MPP+ is the active metabolite of MPTP, a molecule structurally similar to the herbicide Paraquat, known to injure the dopaminergic neurons of the nigrostriatal system in Parkinson’s disease models. Within the cells, MPP+ accumulates in mitochondria where it inhibits complex I of the electron transport chain, resulting in ATP depletion and neuronal impairment/death. So far, MPP+ is recognized as a valuable tool to mimic dopaminergic degeneration in various cell lines. However, despite a large number of studies, a detailed characterization of mitochondrial respiration in neuronal cells upon MPP+ treatment is still missing. By using high-resolution respirometry, we deeply investigated oxygen consumption related to each respiratory state in differentiated neuroblastoma cells exposed to the neurotoxin. Our results indicated the presence of extended mitochondrial damage at the inner membrane level, supported by increased LEAK respiration, and a drastic drop in oxygen flow devoted to ADP phosphorylation in respirometry measurements. Furthermore, prior to complex I inhibition, an enhancement of complex II activity was observed, suggesting the occurrence of some compensatory effect. Overall our findings provide a mechanistic insight on the mitochondrial toxicity mediated by MPP+, relevant for the standardization of studies that employ this neurotoxin as a disease model.

11 May 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
PRPierpaolo Risiglione
Pierpaolo Risiglione
Federica ZinghirinoFederica Zinghirino
Federica Zinghirino
MRMaria Carmela Di Rosa
Maria Carmela Di Rosa
Andrea MagrìAndrea Magrì
Andrea Magrì
Angela MessinaAngela Messina
Angela Messina
Alpha-Synuclein (αSyn) is a protein whose function is still debated, as well as its role in modulation of mitochondrial function in both physiological and pathological conditions. Mitochondrial porins or Voltage-Dependent Anion Channel (VDAC) proteins are the main gates for ADP/ATP and various substrates towards the organelle. Furthermore, they act as a mitochondrial hub for many cytosolic proteins, including αSyn. This review analyzes the main aspects of αSyn-mitochondria interaction, focusing on the role of VDAC and its emerging involvement in the pathological processes.

3 August 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
Andrea MagrìAndrea Magrì
Andrea Magrì
PRPierpaolo Risiglione
Pierpaolo Risiglione
Antonella CaccamoAntonella Caccamo
Antonella Caccamo
BFBeatrice Formicola
Beatrice Formicola
Marianna Flora TomaselloMarianna Flora Tomasello
Marianna Flora Tomasello
Angela MessinaAngela Messina
Angela Messina
Mutations in Cu/Zn Superoxide Dismutase (SOD1) gene represent one of the most common causes of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder that specifically affects motor neurons (MNs). The dismutase-active SOD1 G93A mutant is responsible for the formation of toxic aggregates onto the mitochondrial surface, using the Voltage-Dependent Anion Channel 1 (VDAC1) as an anchor point to the organelle. VDAC1 is the master regulator of cellular bioenergetics and by binding to hexokinases (HKs) it controls apoptosis. In ALS, however, SOD1 G93A impairs VDAC1 activity and displaces HK1 from mitochondria, promoting organelle dysfunction, and cell death. Using an ALS cell model, we demonstrate that a small synthetic peptide derived from the HK1 sequence (NHK1) recovers the cell viability in a dose–response manner and the defective mitochondrial respiration profile relative to the ADP phosphorylation. This correlates with an unexpected increase of VDAC1 expression and a reduction of SOD1 mutant accumulation at the mitochondrial level. Overall, our findings provide important new insights into the development of therapeutic molecules to fight ALS and help to better define the link between altered mitochondrial metabolism and MNs death in the disease.

15 June 2022 in Life
Verified
Journal Article
Open access
PDF file
PRPierpaolo Risiglione
Pierpaolo Risiglione
SCSalvatore Antonio Maria Cubisino
Salvatore Antonio Maria Cubisino
CLCristiana Lucia Rita Lipari
Cristiana Lucia Rita Lipari
Vito De PintoVito De Pinto
Vito De Pinto
Angela MessinaAngela Messina
Angela Messina
Andrea MagrìAndrea Magrì
Andrea Magrì
α-synuclein (αSyn) is a small neuronal protein whose accumulation correlates with Parkinson’s disease. αSyn A53T mutant impairs mitochondrial functions by affecting substrate import within the organelle, activity of complex I and the maximal respiratory capacity. However, the precise mechanism initiating the bioenergetic dysfunction is not clearly understood yet. By overexpressing αSyn A53T in SH-SY5Y cells, we investigated the specific changes in the mitochondrial respiratory profile using High-Resolution Respirometry. We found that αSyn A53T increases dissipative fluxes across the intermembrane mitochondrial space: this does not compromise the oxygen flows devoted to ATP production while it reduces the bioenergetic excess capacity of mitochondria, providing a possible explanation of the increased cell susceptibility observed in the presence of further stress stimuli.